Beta-thalassemia
Open accessThe DOI matches its Crossref record; 4 of the 89 references it cites were found in a registry or an index, and 85 are not checked yet.
Abstract
Beta-thalassemia is caused by the reduced (beta) or absent (beta) synthesis of the beta globin chains of the hemoglobin tetramer. Three clinical and hematological conditions of increasing severity are recognized, i.e., the beta-thalassemia carrier state, thalassemia intermedia, and thalassemia major. The beta-thalassemia carrier state, which results from heterozygosity for beta-thalassemia, is clinically asymptomatic and is defined by specific hematological features. Thalassemia major is a severe transfusion-dependent anemia. Thalassemia intermedia comprehend a clinically and genotypically very heterogeneous group of thalassemia-like disorders, ranging in severity from the asymptomatic carrier state to the severe transfusion-dependent type. The clinical severity of beta-thalassemia is related to the extent of imbalance between the alpha and nonalpha globin chains. The beta globin (HBB) gene maps in the short arm of chromosome 11, in a region containing also the delta globin gene, the embryonic epsilon gene, the fetal A-gamma and G-gamma genes, and a pseudogene (psiB1). Beta-thalassemias are heterogeneous at the molecular level. More than 200 disease-causing mutations have been so far identified. The majority of mutations are single nucleotide substitutions, deletions, or insertions of oligonucleotides leading to frameshift. Rarely, beta-thalassemia results from gross gene deletion. In addition to the variation of the phenotype resulting from allelic heterogeneity at the beta globin locus, the phenotype of beta-thalassemia could also be modified by the action of genetic factors mapping outside the globin gene cluster and not influencing the fetal hemoglobin. Among these factors, the ones best delineated so far are those affecting bilirubin, iron, and bone metabolisms. Because of the high carrier rate for HBB mutations in certain populations and the availability of genetic counseling and prenatal diagnosis, population screening is ongoing in several at-risk populations in the Mediterranean. Population screening associated with genetic counseling was extremely useful by allowing couples at risk to make informed decision on their reproductive choices. Clinical management of thalassemia major consists in regular long-life red blood cell transfusions and iron chelation therapy to remove iron introduced in excess with transfusions. At present, the only definitive cure is bone marrow transplantation. Therapies under investigation are the induction of fetal hemoglobin with pharmacologic compounds and stem cell gene therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803
In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state
Wernig, M., Meissner, A., Foreman, R., Brambrink, T., Ku, M., Hochedlinger, K., Bernstein, B. E., & Jaenisch, R. (2007) · Nature · doi:10.1038/nature05944 · Cited by 2,676
Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload
Anderson, L. (2001) · European Heart Journal · doi:10.1053/euhj.2001.2822 · Cited by 1,682
Common West African HLA antigens are associated with protection from severe malaria
Hill, A. V. S., Allsopp, C. E. M., Kwiatkowski, D., Anstey, N. M., Twumasi, P., Rowe, P. A., Bennett, S., Brewster, D., McMichael, A. J., & Greenwood, B. M. (1991) · Nature · doi:10.1038/352595a0 · Cited by 1,552
Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation
Ganz, T. (2003) · Blood · doi:10.1182/blood-2003-03-0672 · Cited by 1,544
Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin
Hanna, J., Wernig, M., Markoulaki, S., Sun, C.-W., Meissner, A., Cassady, J. P., Beard, C., Brambrink, T., Wu, L.-C., Townes, T. M., et al. (2007) · Science · doi:10.1126/science.1152092 · Cited by 1,202
Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria
McGuire, W., Hill, A. V. S., Allsopp, C. E. M., Greenwood, B. M., & Kwiatkowski, D. (1994) · Nature · doi:10.1038/371508a0 · Cited by 1,169
Rund, D., & Rachmilewitz, E. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050436 · Cited by 939
Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11A
Sankaran, V. G., Menne, T. F., Xu, J., Akie, T. E., Lettre, G., Van Handel, B., Mikkola, H. K. A., Hirschhorn, J. N., Cantor, A. B., & Orkin, S. H. (2008) · Science · doi:10.1126/science.1165409 · Cited by 919
Research works printed but not linked: 5
- Wheatherall DJ, Clegg JB. The thalassemia syndromes. 4th ed. Oxford, England: Blackwell Science Ltd, 2001.
- Weatherall DJ, Clegg JB, Higgs DR, Wood WG. The hemoglobinopathies. In: Scriver CR, Beaudet Al, Sly WS, Valle D, Vogelstein B, editors. The metabolic and molecular bases of inherited disease (OMMBID). Chapter 101. New York, NY: McGraw-Hill, 2002. Available at: www.ommbid.com. Accessed December 31, 2007.
- Rees, 1998, Genetic influenes on bone disease in thalassemia, Blood, 92, S532a
- Dresner Pollak, 2000, Bone mineral metabolism in adults with beta thalassemia major and intermedia, Br J Haematol, 111, 902
- Galanello, 1990, Deletion delta-thalassemia: the 7.2 kb deletion of Corfu delta beta-thalassemia in a non-beta-thalassemia chromosome, Blood, 15, 75:11747
Cited by
Items 201–300 of 721
Cardiac complications in beta-thalassemia: From mice to men
Kumfu, S., Fucharoen, S., Chattipakorn, S. C., & Chattipakorn, N. (2017) · Experimental Biology and Medicine · doi:10.1177/1535370217708977 · Cited by 17
Craniofacial shape in patients with beta thalassaemia: a geometric morphometric analysis
Ρούσσος, Π., Mitsea, A., Halazonetis, D. J., & Sifakakis, I. (2021) · Scientific Reports · doi:10.1038/s41598-020-80234-z · Cited by 15
Volloch, V. (2019) · Annals of Integrative Molecular Medicine · doi:10.33597/aimm.01-1002 · Cited by 20
RNA Engineering for Public Health: Innovations in RNA-Based Diagnostics and Therapeutics
Thavarajah, W., Hertz, L. M., Bushhouse, D. Z., Archuleta, C. M., & Lucks, J. B. (2021) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-101420-014055 · Cited by 19
Genetic Manipulation Strategies for β-Thalassemia: A Review
Zakaria, N. A., Bahar, R., Abdullah, W. Z., Yusoff, A. A. M., Shamsuddin, S., Wahab, R. A., & Johan, M. F. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.901605 · Cited by 24
Deep Learning Assisted Automated Assessment of Thalassaemia from Haemoglobin Electrophoresis Images
Khan, M. S., Ullah, A., Khan, K. N., Riaz, H., Yousafzai, Y. M., Rahman, T., Chowdhury, M. E. H., & Kashem, S. B. A. (2022) · Diagnostics · doi:10.3390/diagnostics12102405 · Cited by 25
Gamage, U., Warnakulasuriya, K., Hansika, S., & Silva, G. N. (2023) · Thalassemia Reports · doi:10.3390/thalassrep13010006 · Cited by 20
Therapeutic role of natural agents in beta-thalassemia: A review
Kukreja, A., Wadhwa, N., & Tiwari, A. (2013) · Journal of Pharmacy Research · doi:10.1016/j.jopr.2013.10.002 · Cited by 19
A reduced curcuminoid analog as a novel inducer of fetal hemoglobin
Chaneiam, N., Changtam, C., Mungkongdee, T., Suthatvoravut, U., Winichagoon, P., Vadolas, J., Suksamrarn, A., Fucharoen, S., & Svasti, S. (2012) · Annals of Hematology · doi:10.1007/s00277-012-1604-1 · Cited by 15
Wilairat, P., Kümpornsin, K., & Chookajorn, T. (2016) · Medical Hypotheses · doi:10.1016/j.mehy.2016.02.022 · Cited by 15
Patel, K., Bhivandkar, S., Desai, R., & Antin, T. (2018) · Annals of Hematology · doi:10.1007/s00277-018-3557-5 · Cited by 16
Quercetin analogs with high fetal hemoglobin-inducing activity
Pabuprapap, W., Wassanatip, Y., Khetkam, P., Chaichompoo, W., Kunkaewom, S., Senabud, P., Hata, J., Chokchaisiri, R., Svasti, S., & Suksamrarn, A. (2019) · Medicinal Chemistry Research · doi:10.1007/s00044-019-02412-7 · Cited by 17
Mukherjee, M., Rahaman, M., Ray, S. K., Shukla, P. C., Dolai, T. K., & Chakravorty, N. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06977-8 · Cited by 24
Settakorn, K., Kongkarnka, S., Chompupoung, A., Svasti, S., Fucharoen, S., Porter, J. B., Srichairatanakool, S., & Koonyosying, P. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.1053060 · Cited by 19
High-efficiency targeted transgene integration via primed micro-homologues
Wang, C., Fang, S., Chen, Y., Tang, N., Jiao, G., Hu, Y., Li, J., Shan, Q., Wang, X., Feng, G., et al. (2023) · Cell Discovery · doi:10.1038/s41421-023-00552-0 · Cited by 16
Phanthong, P., Borwornpinyo, S., Kitiyanant, N., Jearawiriyapaisarn, N., Nuntakarn, L., Saetan, J., Nualkaew, T., Sa‐ngiamsuntorn, K., Anurathapan, U., Dinnyés, A., et al. (2017) · Stem Cells Translational Medicine · doi:10.1002/sctm.16-0121 · Cited by 14
Red Blood Cell Membrane Conductance in Hereditary Haemolytic Anaemias
Petkova-Kirova, P. S., Hertz, L. M., Danielczok, J., Huisjes, R., Makhro, A., Bogdanova, A. Y., Mañú‐Pereira, M. D. M., Corrons, J. V., van Wijk, R., & Kaestner, L. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00386 · Cited by 15
Shah, M., Danish, L., Khan, N. U., Zaman, F. U., Ismail, M., Hussain, M., Pervaiz, R., & Iqbal, A. (2020) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.1310 · Cited by 16
Li, B., Han, X., Ma, J., & Yang, D. (2020) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2020-206588 · Cited by 14
CRISPR/Cas9-mediated β-globin gene knockout in rabbits recapitulates human β-thalassemia
Yang, Y., Kang, X., Hu, S., Chen, B., Xie, Y., Song, B., Zhang, Q., Wu, H., Ou, Z., Xian, Y., et al. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100464 · Cited by 15
Turner, A., Sasse, J., & Váradi, A. (2016) · BMC Medical Genetics · doi:10.1186/s12881-016-0334-y · Cited by 16
Raz, S., Koren, A., Dan, O., & Levin, C. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13279 · Cited by 14
Laboratory diagnosis for thalassemia intermedia: Are we there yet?
Ansari, S. H., Rashid, N., Hanifa, A., Siddiqui, S., Kaleem, B., Naz, A., Perveen, K., Hussain, Z., Ansari, I., Jabbar, Q., et al. (2018) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.22647 · Cited by 14
Darvishi‐Khezri, H., Karami, H., Naderisorki, M., Zahedi, M., Razavi, A., Kosaryan, M., & Aliasgharian, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-78230-4 · Cited by 14
Kang, N., Qiu, W., Wang, B., Tang, D., & Shen, X. (2022) · Molecular Carcinogenesis · doi:10.1002/mc.23404 · Cited by 13
Base Editors-Mediated Gene Therapy in Hematopoietic Stem Cells for Hematologic Diseases
Zhang, C., Xu, J., Wu, Y., Xu, C., & Xu, P. (2024) · Stem Cell Reviews and Reports · doi:10.1007/s12015-024-10715-5 · Cited by 16
Left and right atrioventricular coupling index in patients with beta-thalassemia major
Meloni, A., Saba, L., Positano, V., Pistoia, L., Spasiano, A., Putti, M. C., Casini, T., Cossu, A., Corigliano, E., Massa, A., et al. (2024) · The International Journal of Cardiovascular Imaging · doi:10.1007/s10554-024-03146-3 · Cited by 13
Prenatal Diagnosis of β-Thalassemia and Other Hemoglobinopathies in Southwestern Turkey
Mendilcioğlu, İ., Yakut, S., Keser, İ., Şimşek, M., Yeşilipek, A., Bağcı, G., & Lüleci, G. (2011) · Hemoglobin · doi:10.3109/03630269.2010.544607 · Cited by 13
Breveglieri, G., Travan, A., D’Aversa, E., Cosenza, L. C., Pellegatti, P., Guerra, G., Gambari, R., & Borgatti, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172756 · Cited by 13
Web-based expert system with quick response code for beta-thalassemia management
Banjar, H. R., Zaher, G., Almutiry, H. S., Alshamarni, A. S. A., Almouhana, G. I., Alahwal, H. M., Bahashwan, S., Barefah, A., Alnajjar, S. A., & Alharbi, H. (2021) · Health Informatics Journal · doi:10.1177/1460458221989397 · Cited by 13
Rostami, T., Kasaeian, A., Maleki, N., Nikbakht, M., Kiumarsi, A., Tavangar, S. M., Taheri, A. P. H., Mousavi, S. A., & Ghavamzadeh, A. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02242-8 · Cited by 15
Giddings, L., Lountos, G. T., Kim, K. W., Brockley, M. W., Needle, D., Cherry, S., Tropea, J. E., & Waugh, D. S. (2021) · PLoS ONE · doi:10.1371/journal.pone.0248385 · Cited by 15
Dursun, F. E., Açıksarı, G., Özkök, S., & İncealtın, O. (2021) · International journal of cardiac imaging · doi:10.1007/s10554-021-02421-x · Cited by 13
Clinical Characteristics of Pediatric Thalassemia in Korea: A Single Institute Experience
Hong, C. R., Kang, H. J., Lee, J. W., Kim, H., Kim, N. H., Park, K. D., Park, J. D., Seong, M., Park, S. S., Shin, H. Y., et al. (2013) · Journal of Korean Medical Science · doi:10.3346/jkms.2013.28.11.1645 · Cited by 13
Chondrou, V., Kolovos, P., Sgourou, A., Kourakli, A., Pavlidaki, A., Kastrinou, V., John, A., Symeonidis, A. S., Ali, B. R., Papachatzopoulou, A., et al. (2017) · Human Genomics · doi:10.1186/s40246-017-0120-8 · Cited by 13
Ocular findings in patients with transfusion-dependent β-thalassemia in southern Iran
Haghpanah, S., Zekavat, O. R., Bordbar, M., Karimi, M., Zareifar, S., Safaei, S., Ramzi, M., & Ashraf, H. (2020) · BMC Ophthalmology · doi:10.1186/s12886-020-01647-y · Cited by 13
Cui, J., Azimi, M., Baysdorfer, C., Vichinsky, E. P., & Hoppe, C. C. (2013) · Hemoglobin · doi:10.3109/03630269.2013.782461 · Cited by 14
Genetic syndromes leading to male infertility: a systematic review
Cheng, L. G., Huang, S. L., & Hwang, K. (2025) · Fertility and Sterility · doi:10.1016/j.fertnstert.2025.03.014 · Cited by 13
Saha, S., Ghosh, S., Basu, K., & Bhattacharyya, M. (2020) · Journal of Hematopathology · doi:10.1007/s12308-020-00407-7 · Cited by 13
Gene Therapy: A Revolutionary Step in Treating Thalassemia
Salama, R. A. A., Qureshi, G. S. A., Safdar, M., Raafat, A., Janardhan, G., Elshamy, H. A. H., & Jhancy, M. (2024) · Hematology Reports · doi:10.3390/hematolrep16040064 · Cited by 15
Evaluation of Ion Torrent next-generation sequencing for thalassemia diagnosis
Chen, P., Yu, X., Huang, H., Zeng, W., He, X., Liu, M., & Huang, B. (2020) · Journal of International Medical Research · doi:10.1177/0300060520967778 · Cited by 13
Lama, R., Yusof, W., Shrestha, T. R., Hanafi, S., Bhattarai, M., Hassan, R., & Zilfalil, B. A. (2021) · Hematology/Oncology and Stem Cell Therapy · doi:10.1016/j.hemonc.2021.01.004 · Cited by 12
Thalidomide-induced Stroke in a Child With Thalassemia Major
Gunaseelan, S., & Prakash, A. (2017) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0000000000000860 · Cited by 12
Ricchi, P., Meloni, A., Costantini, S., Spasiano, A., Matola, T. D., Pepe, A., Cinque, P., & Filosa, A. (2017) · Annals of Hematology · doi:10.1007/s00277-017-3057-z · Cited by 11
Oxidative Stress and Iron Overload in β-Thalassemia: An Overview
Sposi, N. M. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.90492 · Cited by 18
An introduction to genome editing CRISPR-Cas systems
Singh, V. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818140-9.00001-5 · Cited by 18
Synergistic Effect of Simvastatin and Romidepsin on Gamma-globin Gene Induction.
Habibi, H., Atashi, A., Abroun, S., & Noruzinia, M. (2019) · PubMed Central · doi:10.22074/cellj.2019.5589 · Cited by 12
Shahid, S., Nadeem, M., Zahid, D., Hassan, J., Ansari, S. H., & Shamsi, T. S. (2017) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.332.11834 · Cited by 12
Genotyping of single nucleotide polymorphism by probe-gated silica nanoparticles
Ercan, M. K., Özalp, V. C., & Tuna, B. G. (2017) · Analytical Biochemistry · doi:10.1016/j.ab.2017.09.004 · Cited by 12
Settakorn, K., Hantrakool, S., Petiwathayakorn, T., Hutachok, N., Tantiworawit, A., Charoenkwan, P., Chalortham, N., Chompupoung, A., Paradee, N., Koonyosying, P., et al. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1248742 · Cited by 13
Nucleic Acid Therapy for β-Thalassemia
d’Arqom, A. (2020) · Biologics · doi:10.2147/btt.s265767 · Cited by 16
Vitamin D levels and left ventricular function in beta-thalassemia major with iron overload
Pala, M., Bhat, K. G., Manya, S. M., Joseph, N., & Harish, S. (2023) · European Journal of Pediatrics · doi:10.1007/s00431-023-04830-7 · Cited by 11
Molecular Characterization of β-Thalassemia Intermedia in Southeast Iran
Miri‐Moghaddam, E., Bahrami, S., Naderi, M., Bazı, A., & Karimipoor, M. (2016) · Hemoglobin · doi:10.3109/03630269.2016.1167735 · Cited by 11
Muhammad, R., Shakeel, M., Rehman, S. U., & Lodhi, M. A. (2017) · Hemoglobin · doi:10.1080/03630269.2017.1330210 · Cited by 11
Borgio, J. F., AbdulAzeez, S., Almandil, N. B., Naserullah, Z. A., Al‐Jarrash, S., AlSuliman, A. M., ElFakharay, H. I., Qaw, F. S., Alabdrabalnabi, F. M., Alkhalifah, M. K., et al. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.8033 · Cited by 15
Cardiac involvement by CMR in different genotypic groups of thalassemia major patients
Pistoia, L., Meloni, A., Salvadori, S., Spasiano, A., Lisi, R., Rosso, R., Maggio, A., D’Ascola, D. G., Cuccia, L., Mangione, M., et al. (2019) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2019.01.008 · Cited by 11
Molecular characterization of β-thalassemia intermedia in the West Bank, Palestine
Faraon, R., Daraghmah, M., Samarah, F., & Srour, M. A. (2019) · BMC Hematology · doi:10.1186/s12878-019-0135-6 · Cited by 11
Zhu, F., Wei, X., Cai, D., Pang, D., Zhong, J., Liang, M., Zuo, Y., Xu, X., & Shang, X. (2019) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.13021 · Cited by 11
Hossaini, S. K. E., & Haeri, M. R. (2019) · Journal of Hematopathology · doi:10.1007/s12308-019-00363-x · Cited by 15
Retinal nerve fiber layer thickness and retinal vessel calibers in children with thalassemia minor
Acer, S., Balcı, Y. I., Pekel, G., Ongun, G. T., Polat, A., Çetin, E. N., & Yağcı, R. (2016) · SAGE Open Medicine · doi:10.1177/2050312116661683 · Cited by 13
Karimi, M., Zarei, T., Haghpanah, S., Moghadam, M., Ebrahimi, A., Rezaei, N., Heidari, G., Vazin, A., Khavari, M., & Miri, H. (2017) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0000000000000779 · Cited by 12
Expression of CD55, CD59, and CD35 on red blood cells of β-thalassaemia patients
Kurtoğlu, A. U., Koçtekin, B., Kurtoğlu, E., Yıldız, M., & Bozkurt, S. (2017) · Central European Journal of Immunology · doi:10.5114/ceji.2017.67321 · Cited by 11
Polyneuropathy and myopathy in beta-thalassemia major patients
Nemtsas, P., Arnaoutoglou, M., Perifanis, V., Koutsouraki, E., Spanos, G., Arnaoutoglou, N. A., Chalkia, P., Pantelidou, D., & Orologas, A. (2018) · Annals of Hematology · doi:10.1007/s00277-018-3251-7 · Cited by 11
Sharifi, Z., Rahiminejad, F., Joudaki, A., Sarhaddi, A. B., Farahzadi, H., Keshvar, Y., Golnabi, F., Naderi, S., Yazdani, R., Shafaat, M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-43892-2 · Cited by 13
Exa-cel in Children with Transfusion-Dependent β-Thalassemia or Sickle Cell Disease
Frangoul, H., de la Fuente, J., Chopra, Y. R., Meisel, R., Amrolia, P. J., Algeri, M., Sharma, A., Cappellini, M. D., Corbacioglu, S., Kattamis, A., et al. (2026) · New England Journal of Medicine · doi:10.1056/nejmoa2603387 · Cited by 12
Anastasiadi, A. T., Tzounakas, V. L., Dzieciątkowska, M., Arvaniti, V.-Z., Papageorgiou, E. G., Papassideri, I. S., Stamoulis, K. E., D’Alessandro, A., Kriebardis, A. G., & Antonelou, M. H. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.907444 · Cited by 10
Lin, Y., Agarwal, A. M., Anderson, L. C., & Marshall, A. G. (2023) · Journal of Mass Spectrometry and Advances in the Clinical Lab · doi:10.1016/j.jmsacl.2023.01.004 · Cited by 11
Left atrial strain in patients with β-thalassemia major: a cross-sectional CMR study
Meloni, A., Saba, L., Positano, V., Pistoia, L., Porcu, M., Massei, F., Sanna, P. M. G., Longo, F., Giovangrossi, P., Argento, C., et al. (2024) · European Radiology · doi:10.1007/s00330-024-10667-x · Cited by 10
Deferasirox for the treatment of iron overload in non-transfusion-dependent thalassemia
Taher, A. T., Temraz, S. N., & Cappellini, M. D. (2013) · Expert Review of Hematology · doi:10.1586/17474086.2013.827411 · Cited by 11
Transcriptional Repressors of Fetal Globin Genes as Novel Therapeutic Targets in Beta-Thalassemia
Martino, M. D., Sessa, R., Storino, M. R., Giuliano, M., Trombetti, S., Catapano, R., Bianco, A. L., Izzo, P., & Grosso, M. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.90762 · Cited by 15
Darvishi‐Khezri, H., Aliasgharian, A., Naderisorki, M., Kosaryan, M., Ghazaiean, M., Fallah, H., Zahedi, M., & Karami, H. (2022) · Scientific Reports · doi:10.1038/s41598-022-22234-9 · Cited by 10
Molecular characterization of HBB gene mutations in beta-thalassemia patients of Southern Iraq
Al-Musawi, A. H. O., Aziz, H. M., Khudair, S., & Saleh, T. H. (2022) · Biomedicine · doi:10.51248/.v42i5.2280 · Cited by 10
Molecular regulatory mechanisms of erythropoiesis and related diseases
Zhu, L., He, C., Guo, Y., Liu, H., & Zhang, S. (2023) · European Journal Of Haematology · doi:10.1111/ejh.14028 · Cited by 11
Meloni, A., Saba, L., Positano, V., Pistoia, L., Campanella, A., Spasiano, A., Putti, M. C., Fotzi, I., Cossu, A., Corigliano, E., et al. (2024) · International Journal of Cardiology · doi:10.1016/j.ijcard.2024.132319 · Cited by 13
Craniofacial manifestations of β-thalassemia major
Javid, B., & Said-Al-Naief, N. A. H. (2014) · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · doi:10.1016/j.oooo.2014.08.020 · Cited by 10
Studying disorders of vertebrate iron and heme metabolism using zebrafish
van der Vorm, L. N., & Paw, B. H. (2016) · Methods in cell biology · doi:10.1016/bs.mcb.2016.10.008 · Cited by 10
Biochemical and Molecular Analysis of the Hb Lepore Boston Washington in a Syrian Homozygous Child
Pirastru, M., Manca, L., Trova, S., & Mereu, P. (2017) · BioMed Research International · doi:10.1155/2017/1261972 · Cited by 10
Raz, S., Koren, A., & Levin, C. (2019) · British Journal of Haematology · doi:10.1111/bjh.15957 · Cited by 10
Falcone, V., Heinzl, F., Itariu, B. K., Reischer, T., Springer, S., Muin, D. A., Pateisky, P., Foessleitner, P., Ott, J., Farr, A., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11072050 · Cited by 11
Pissard, S., Raclin, V., Lacan, P., Garcia, C., Aguilar‐Martinez, P., Francina, A., & Joly, P. (2012) · Clinica Chimica Acta · doi:10.1016/j.cca.2012.08.030 · Cited by 10
Refractive errors and ocular biometry components in thalassemia major patients
Heydarian, S., Jafari, R., & Karami, H. (2015) · International Ophthalmology · doi:10.1007/s10792-015-0161-8 · Cited by 10
Chalikiopoulou, C., Tavianatou, A., Sgourou, A., Kourakli, A., Kelepouri, D., Chrysanthakopoulou, M., Kanelaki, V.-K., Mourdoukoutas, E., Siamoglou, S., John, A., et al. (2016) · Pharmacogenomics · doi:10.2217/pgs.16.1 · Cited by 10
Gene spectrum analysis of thalassemia for people residing in northern China
Yang, Z., Zhou, W., Cui, Q., Qiu, L., & Han, B. (2019) · BMC Medical Genetics · doi:10.1186/s12881-019-0818-7 · Cited by 12
Iyevhobu, K. O., Omolumen Lucky, E., Okobi, T., Usoro, E. R., Ivie, A. A., Ken-Iyevhobu, B. A., & Victoria, O. O. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.111682 · Cited by 14
Machine Learning-Based Prediction of Thalassemia: A Review
Abdulkarim, D., & Abdulazeez, A. M. (2024) · Indonesian Journal of Computer Science · doi:10.33022/ijcs.v13i3.4035 · Cited by 15
Chassanidis, C., Boutou, E., Voskaridou, E., & Balassopoulou, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157393 · Cited by 9
Elsadek, A. M., Hassan, N., Shahwan, M. J., & Jairoun, A. A. (2022) · Journal of Community Health · doi:10.1007/s10900-022-01066-8 · Cited by 9
Alashkar, F., Klump, H., Lange, C. P., Proske, P., Schüßler, M., Yamamoto, R., Carpinteiro, A., Berliner, C., Schlosser, T. W., Röth, A., et al. (2022) · European Journal Of Haematology · doi:10.1111/ejh.13849 · Cited by 9
Eroğlu, A. G., Murt, N. U., Karakaş, H., Yüksel, E. K., Akyel, N. G., Çığ, G., Adaletli, İ., Özdemir, N., Türkkan, E., & Celkan, T. T. (2022) · Echocardiography · doi:10.1111/echo.15453 · Cited by 10
Balearic archipelago: three islands, three beta‐thalassemia population patterns
López‐Escribano, H., Parera, M. M., Guix, P., Serra, J. S., Gutierrez, A. M., Balsells, D., Berini, E. O., Ja, C., Ramón, M., & Picornell, A. (2012) · Clinical Genetics · doi:10.1111/j.1399-0004.2012.01864.x · Cited by 9
Zhang, W., Coba, M. P., & Sun, F. (2016) · BMC Systems Biology · doi:10.1186/s12918-015-0247-y · Cited by 11
Chaudhary, S. A., Dhawan, D., Bagali, P. G., Chaudhary, P. S., Chaudhary, A., Singh, S. K., & Vudathala, S. (2016) · Molecular Genetics and Metabolism Reports · doi:10.1016/j.ymgmr.2016.04.002 · Cited by 9
β-Thalassemia gene mutations in Antalya, Turkey: results from a single centre study
Kurtoğlu, A. U., Karakuş, V., Erkal, Ö., & Kurtoğlu, E. (2016) · Hemoglobin · doi:10.1080/03630269.2016.1256818 · Cited by 9
Chattong, S., Ruangwattanasuk, O., Yindeedej, W., Setpakdee, A., & Manotham, K. (2017) · Gene Therapy · doi:10.1038/gt.2017.42 · Cited by 10
New Advances in Evaluation of Hearing in a Sample of Egyptian Children with β-Thalassemia Major
Elzaree, F. A., Shehata, M. A., Atti, M. A., Elzaree, G., & El-Kassas, G. M. (2019) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2019.316 · Cited by 9
da Silva, J. P. M. D. O., Brugnerotto, A. F., Romanello, K. S., Teixeira, K. K. L., Lanaro, C., Duarte, A. S. S., Costa, G. G. L., Araújo, A. D. S., Bezerra, M., Domingos, I. F., et al. (2019) · British Journal of Haematology · doi:10.1111/bjh.16062 · Cited by 9
Clinical Laboratory Manifestation and Molecular Diagnosis of β-Thalassemia Patients in Iraq
AlMosawi, R. H. N., Al-Rashedi, N. A. M., & Ayoub, N. I. (2019) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0000000000001656 · Cited by 10
Haghpanah, S., Zarei, T., Eshghi, P., Zekavat, O. R., Bordbar, M., Hoormand, M., & Karimi, M. (2018) · Annals of Hematology · doi:10.1007/s00277-018-3392-8 · Cited by 12
Omics Studies in Hemoglobinopathies
Katsantoni, E. Z. (2019) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-019-00386-1 · Cited by 10
Topal, Y., Topal, H., Ceyhan, M. N., Azik, F. M., Çapanoğlu, M., & Kocabaş, C. N. (2015) · Hemoglobin · doi:10.3109/03630269.2015.1046185 · Cited by 9
Metadata
- Authors
- Cao, A., & Galanello, R.
- Affiliations
- National Research Council (IT)
- University of Cagliari (IT)
- Corresponding author
- Cao, Antonio
- Venue
- Genetics in Medicine
- Publisher
- Elsevier BV
- Published
- 2010-02
- Volume
- 12
- Issue
- 2
- Pages
- 61-76
- ISSN
- 1098-3600 (ISSN-L)
- OpenAlex
- W4210970197
- Cited by
- 722
- References
- 4
- Citations by year
- 2026: 43 · 2025: 48 · 2024: 63 · 2023: 61 · 2022: 60 · 2021: 66 · 2020: 69 · 2019: 64 · 2018: 48 · 2017: 58 · 2016: 52 · 2015: 24 · 2014: 14 · 2013: 20 · 2012: 15
- FWCI
- 1.82
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 4370 d)
- Locations
- Genetics in Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Keywords
- beta-thalassemia, beta-globin gene, HBB mutations, thalassemia major, thalassemia intermedia, transfusion-dependent anemia, iron chelation therapy, bone marrow transplantation, fetal hemoglobin induction, genetic counseling, prenatal diagnosis, chromosome 11
- MeSH terms
- Female, Multigene Family, Genetic Testing, Globins, Genetic Carrier Screening, Humans, Pregnancy, Prenatal Diagnosis, Bone Marrow Transplantation, beta-Thalassemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.